Oncology & Cancer

Late morbidity, mortality down for survivors of childhood ALL

(HealthDay)—Contemporary survivors of childhood acute lymphoblastic leukemia (ALL) have reduced late morbidity and mortality, according to a study published online July 24 in the Journal of Clinical Oncology.

Oncology & Cancer

Survivors of adolescent, young adult ALL may suffer late effects

(HealthDay)—Survivors of adolescent and young adult (AYA) acute lymphoblastic leukemia (ALL) may experience late effects, with a high incidence of subsequent endocrine disease and cardiac disease, according to a study published ...

Oncology & Cancer

Assessing cancer diagnosis in children with birth defects

Scientific studies suggest that children with birth defects are at increased risk of cancer. However, it has not been assessed whether the type of cancer, the age at which they are diagnosed or the extent of cancer spread ...

Oncology & Cancer

Infection risk up in month after CAR T-cell immunotherapy

(HealthDay)—For children and young adults receiving CD19 chimeric antigen receptor (CAR) T-cell infusion (CTI), infection rates increase in the first month after treatment and then decrease, according to a study published ...

page 8 from 33